T cell differentiation drives the negative selection of pathogenic mitochondrial DNA variants.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
11 2023
Historique:
received: 13 07 2023
revised: 08 08 2023
accepted: 09 08 2023
medline: 4 9 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: epublish

Résumé

Pathogenic mitochondrial DNA (mtDNA) single-nucleotide variants are a common cause of adult mitochondrial disease. Levels of some variants decrease with age in blood. Given differing division rates, longevity, and energetic requirements within haematopoietic lineages, we hypothesised that cell-type-specific metabolic requirements drive this decline. We coupled cell-sorting with mtDNA sequencing to investigate mtDNA variant levels within progenitor, myeloid, and lymphoid lineages from 26 individuals harbouring one of two pathogenic mtDNA variants (m.3243A>G and m.8344A>G). For both variants, cells of the T cell lineage show an enhanced decline. High-throughput single-cell analysis revealed that decline is driven by increasing proportions of cells that have cleared the variant, following a hierarchy that follows the current orthodoxy of T cell differentiation and maturation. Furthermore, patients with pathogenic mtDNA variants have a lower proportion of T cells than controls, indicating a key role for mitochondrial function in T cell homeostasis. This work identifies the ability of T cell subtypes to selectively purify their mitochondrial genomes, and identifies pathogenic mtDNA variants as a new means to track blood cell differentiation status.

Identifiants

pubmed: 37652671
pii: 6/11/e202302271
doi: 10.26508/lsa.202302271
pmc: PMC10471888
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204709/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203105/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 219562/Z/19Z
Pays : United Kingdom

Informations de copyright

© 2023 Franklin et al.

Références

Ann Neurol. 1992 Apr;31(4):391-8
pubmed: 1586140
Ann Neurol. 2015 May;77(5):753-9
pubmed: 25652200
Nat Immunol. 2020 Sep;21(9):1022-1033
pubmed: 32661364
Bioinformatics. 2009 Sep 1;25(17):2283-5
pubmed: 19542151
Am J Hum Genet. 2008 Feb;82(2):333-43
pubmed: 18252214
Adv Nutr. 2016 Jul 15;7(4):798S-805S
pubmed: 27422517
Biochem Int. 1990 Aug;21(5):789-96
pubmed: 2124116
BBA Clin. 2016 Apr 29;6:19-24
pubmed: 27331024
Int Rev Immunol. 2016 Nov;35(6):477-488
pubmed: 26606199
Nature. 1990 Dec 13;348(6302):651-3
pubmed: 2102678
Clin Genet. 2018 Apr;93(4):925-928
pubmed: 29266179
J Med Genet. 2007 Jan;44(1):69-74
pubmed: 16950816
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
FEBS Lett. 2021 Apr;595(8):1003-1024
pubmed: 33513266
EMBO Mol Med. 2018 Jun;10(6):
pubmed: 29735722
Ann Clin Transl Neurol. 2018 Feb 07;5(3):333-345
pubmed: 29560378
Nat Commun. 2021 Nov 4;12(1):6409
pubmed: 34737295
Cell. 1990 Jun 15;61(6):931-7
pubmed: 2112427
Nat Rev Genet. 2015 Sep;16(9):530-42
pubmed: 26281784
Oncotarget. 2017 Sep 1;8(43):73627-73639
pubmed: 29088732
Cell Metab. 2017 Jun 6;25(6):1254-1268.e7
pubmed: 28591633
Immunity. 2012 Jan 27;36(1):68-78
pubmed: 22206904
Am J Hum Genet. 2001 Jan;68(1):238-40
pubmed: 11085913
Biochem J. 2003 Mar 15;370(Pt 3):751-62
pubmed: 12467494
Mitochondrion. 2007 Dec;7(6):374-85
pubmed: 17890163
N Engl J Med. 2020 Oct 15;383(16):1556-1563
pubmed: 32786181
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3622-30
pubmed: 24003133
Nat Commun. 2021 Dec 6;12(1):6997
pubmed: 34873176
Nature. 2019 Sep;573(7773):E2
pubmed: 31447485
J Neurol Sci. 1998 Nov 26;161(1):36-9
pubmed: 9879679
Int Immunol. 1999 Jul;11(7):1027-33
pubmed: 10383934
Biochem J. 1996 Sep 1;318 ( Pt 2):401-7
pubmed: 8809026
PLoS Biol. 2019 Oct 29;17(10):e3000383
pubmed: 31661488
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
J Neurol. 2016 May;263(5):961-972
pubmed: 26995359
Biochim Biophys Acta. 2008 May;1782(5):317-25
pubmed: 18319067
Nature. 2017 Dec 21;552(7685):362-367
pubmed: 29236685
Open Biol. 2020 May;10(5):200061
pubmed: 32428418
J Neurol. 2014 Mar;261(3):504-10
pubmed: 24375076
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4221-5
pubmed: 1584755
Nat Rev Immunol. 2005 Nov;5(11):844-52
pubmed: 16239903
J Immunol. 2006 Jul 15;177(2):852-62
pubmed: 16818739
Neurology. 2006 Jun 27;66(12):1932-4
pubmed: 16801664
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
Cell Rep. 2016 Dec 20;17(12):3142-3152
pubmed: 28009285
Mol Biol Evol. 2022 May 3;39(5):
pubmed: 35482398
J Inherit Metab Dis. 2012 Nov;35(6):1059-69
pubmed: 22403016
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):465-468, 468.e1
pubmed: 25017538
Am J Hum Genet. 1992 Dec;51(6):1187-200
pubmed: 1334369

Auteurs

Imogen G Franklin (IG)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.

Paul Milne (P)

https://ror.org/01kj2bm70 Haematopoiesis and Immunogenomics Laboratory, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.

Jordan Childs (J)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.

Róisín M Boggan (RM)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.

Isabel Barrow (I)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, England.
https://ror.org/01kj2bm70 NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, England.

Conor Lawless (C)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.

Gráinne S Gorman (GS)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, England.
https://ror.org/01kj2bm70 NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, England.

Yi Shiau Ng (YS)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, England.

Matthew Collin (M)

https://ror.org/01kj2bm70 Haematopoiesis and Immunogenomics Laboratory, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England matthew.collin@ncl.ac.uk.

Oliver M Russell (OM)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.
https://ror.org/01kj2bm70 NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, England.

Sarah J Pickett (SJ)

https://ror.org/01kj2bm70 Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England sarah.pickett@ncl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH